Browsing Tag
Antimicrobial Resistance
8 posts
Nano-Mupirocin breakthrough: Revium Rx targets MRSA and VRE with next-generation antibiotic innovation
Find out how Revium Rx’s Nano-Mupirocin could redefine antibiotic therapy against MRSA and VRE and reshape the global antimicrobial resistance market.
Recce Pharmaceuticals stock rises as Phase 3 trial begins in Indonesia: Can RCE prove its anti-infective breakthrough?
Recce Pharmaceuticals (ASX:RCE) stock gained as it began a Phase 3 trial in Indonesia for diabetic foot infections. Explore what this means for investors and AMR.
Lumos Diagnostics (ASX: LDX) reaches 500-patient milestone in FebriDx CLIA study
Lumos Diagnostics hits a key 500-patient milestone in its FebriDx CLIA waiver study, triggering BARDA funds. FDA application expected by October 2025.
Recce Pharmaceuticals advances R327 Gel towards Phase 3 after promising Phase II trial
Recce Pharmaceuticals Limited has announced significant success in its Phase II trial of RECCE 327 topical gel (R327G),…
FDA approves EMBLAVEO to combat complicated intra-abdominal infections with limited treatment options
The U.S. Food and Drug Administration (FDA) has granted approval for EMBLAVEO (aztreonam and avibactam), marking a significant…
Eli Lilly and OpenAI forge pioneering alliance to combat antimicrobial resistance
Eli Lilly and Company (NYSE: LLY) has entered into a partnership with OpenAI to harness generative AI for…
Mid Yorkshire NHS Trust adopts Ondine’s Steriwave to combat surgical site infections
Mid Yorkshire Teaching NHS Trust has taken a significant step forward in the battle against surgical site infections…
Akthelia and University of Iceland lead €6M EU-funded initiative to battle antimicrobial resistance
Akthelia Pharmaceuticals wins €6M EU Horizon grant for IN-ARMOR, a groundbreaking antimicrobial resistance project. Learn how it could change global health today.